Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Lowered to $120 but BofA Securities Sees FY Guidance as Realistic

May 27, 2022 7:30 AM
BofA Securities analyst Travis Steed lowered the price target on Medtronic, Inc. (NYSE: MDT) to $120.00 (from $135.00) after the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles